Advanced Research Our products are thoughtfully crafted using the latest research and proudly carry an NPN license from Health Canada, ensuring their safety and efficacy
Semaglutide in Type 2 Diabetic Adult Patients In a clinical trial, semaglutide showed superiority over dulaglutide to improve glucose control and weight loss greater than 5% in type 2 diabetic adult patients.[12] The study was randomized and open-label, meaning the participants knew what medication they received
Furthermore, ongoing research endeavors are needed to further elucidate the long-term efficacy, safety, and tolerability of semaglutide in UC management, as well as its potential role in combination therapy and personalized treatment approaches
Call Marina Fay, PA-C at (754) 340-0795 to schedule a Medical Weight Loss Injections consultation
Medication sourcing matters clinically
For context on the cross-border brand option: as of April 2026, US patients importing brand-name Ozempic from certified Canadian pharmacies were paying around $380 USD per month
/assets/images/provider/photos/2775905.jpeg)
